[go: up one dir, main page]
More Web Proxy on the site http://driver.im/
KEGG   DRUG: Phenytoin sodium
Entry
D02103                      Drug                                   
Name
Phenytoin sodium (USP);
Phenytoin sodium for injection (JP18);
Aleviatin (TN);
Dilantin (TN)
Product
  Generic
DILANTIN (Parke-Davis Div of Pfizer), DILANTIN (REMEDYREPACK), EXTENDED PHENYTOIN SODIUM (A-S Medication Solutions), EXTENDED PHENYTOIN SODIUM (American Health Packaging), EXTENDED PHENYTOIN SODIUM (American Health Packaging), EXTENDED PHENYTOIN SODIUM (Amneal Pharmaceuticals LLC), EXTENDED PHENYTOIN SODIUM (Aphena Pharma Solutions - Tennessee), EXTENDED PHENYTOIN SODIUM (Aurobindo Pharma Limited), EXTENDED PHENYTOIN SODIUM (AvKARE), EXTENDED PHENYTOIN SODIUM (Cardinal Health 107), EXTENDED PHENYTOIN SODIUM (Major Pharmaceuticals), EXTENDED PHENYTOIN SODIUM (NCS HealthCare of KY), EXTENDED PHENYTOIN SODIUM (PD-Rx Pharmaceuticals), EXTENDED PHENYTOIN SODIUM (REMEDYREPACK), PHENYTEK (Mylan Pharmaceuticals), PHENYTOIN SODIUM (A-S Medication Solutions), PHENYTOIN SODIUM (A-S Medication Solutions), PHENYTOIN SODIUM (Acella Pharmaceuticals), PHENYTOIN SODIUM (Bryant Ranch Prepack), PHENYTOIN SODIUM (Bryant Ranch Prepack), PHENYTOIN SODIUM (HF Acquisition Co LLC), PHENYTOIN SODIUM (HF Acquisition Co LLC), PHENYTOIN SODIUM (Henry Schein), PHENYTOIN SODIUM (Henry Schein), PHENYTOIN SODIUM (Hikma Pharmaceuticals USA), PHENYTOIN SODIUM (Hikma Pharmaceuticals USA), PHENYTOIN SODIUM (Medical Purchasing Solutions), PHENYTOIN SODIUM (NCS HealthCare of KY), PHENYTOIN SODIUM (Proficient Rx LP), PHENYTOIN SODIUM (REMEDYREPACK), PHENYTOIN SODIUM (REMEDYREPACK), PHENYTOIN SODIUM (REMEDYREPACK), PHENYTOIN SODIUM (RPK Pharmaceuticals), PHENYTOIN SODIUM (RPK Pharmaceuticals), PHENYTOIN SODIUM (Sun Pharmaceutical Industries), PHENYTOIN SODIUM (Sun Pharmaceutical Industries), PHENYTOIN SODIUM (Taro Pharmaceuticals U.S.A.), PHENYTOIN SODIUM (Unichem Pharmaceuticals (USA))
Formula
C15H11N2O2. Na
Exact mass
274.0718
Mol weight
274.25
Structure
Simcomp
Class
Neuropsychiatric agent
 DG03199  Antiepileptic agent
  DG02031  Hydantoin antiepileptic
Metabolizing enzyme substrate
 DG01642  CYP2C9 substrate
 DG01639  CYP2C19 substrate
Metabolizing enzyme inducer
 DG02891  CYP2B6 inducer
 DG02853  CYP3A/CYP3A4 inducer
Transporter inducer
 DG01893  ABCB1 inducer
Remark
Therapeutic category: 1132
ATC code: N03AB02
Chemical structure group: DG00846
Product (DG00846): D00512<JP/US> D02103<JP/US>
Efficacy
Antiepileptic
Comment
Hydantoin derivative
Target
SCN1A [HSA:6323] [KO:K04833]
SCN2A [HSA:6326] [KO:K04834]
SCN3A [HSA:6328] [KO:K04836]
SCN4A [HSA:6329] [KO:K04837]
SCN5A [HSA:6331] [KO:K04838]
SCN8A [HSA:6334] [KO:K04840]
SCN9A [HSA:6335] [KO:K04841]
SCN10A [HSA:6336] [KO:K04842]
SCN11A [HSA:11280] [KO:K04843]
  Pathway
hsa04728  Dopaminergic synapse
Metabolism
Enzyme: CYP2C9 [HSA:1559]; CYP2C19 [HSA:1557]
Interaction
CYP induction: CYP3A [HSA:1576 1577 1551], CYP2B6 [HSA:1555]
Transporter induction: ABCB1 [HSA:5243]
Structure map
map07033  Anticonvulsants
map07231  Sodium channel blocking drugs
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 N NERVOUS SYSTEM
  N03 ANTIEPILEPTICS
   N03A ANTIEPILEPTICS
    N03AB Hydantoin derivatives
     N03AB02 Phenytoin
      D02103  Phenytoin sodium (USP) <JP/US>
USP drug classification [BR:br08302]
 Anticonvulsants
  Sodium Channel Agents
   Phenytoin
    D02103  Phenytoin sodium (USP)
Therapeutic category of drugs in Japan [BR:br08301]
 1  Agents affecting nervous system and sensory organs
  11  Agents affecting central nervous system
   113  Antiepileptics
    1132  Hydantoins
     D02103  Phenytoin sodium (USP); Phenytoin sodium for injection (JP18)
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG03199  Antiepileptic agent
   DG02031  Hydantoin antiepileptic
    DG00846  Phenytoin
     D02103  Phenytoin sodium
 Metabolizing enzyme substrate
  DG01642  CYP2C9 substrate
   DG00846  Phenytoin
    D02103  Phenytoin sodium
  DG01639  CYP2C19 substrate
   DG00846  Phenytoin
    D02103  Phenytoin sodium
 Metabolizing enzyme inducer
  DG02891  CYP2B6 inducer
   DG00846  Phenytoin
    D02103  Phenytoin sodium
  DG02853  CYP3A/CYP3A4 inducer
   DG00846  Phenytoin
    D02103  Phenytoin sodium
 Transporter inducer
  DG01893  ABCB1 inducer
   DG00846  Phenytoin
    D02103  Phenytoin sodium
Drug classes [BR:br08332]
 Neuropsychiatric agent
  DG03199  Antiepileptic agent
   D02103  Phenytoin sodium
Target-based classification of drugs [BR:br08310]
 Ion channels
  Voltage-gated ion channels
   Sodium channels
    SCN1A
     D02103  Phenytoin sodium (USP) <JP/US>
    SCN2A
     D02103  Phenytoin sodium (USP) <JP/US>
    SCN3A
     D02103  Phenytoin sodium (USP) <JP/US>
    SCN4A
     D02103  Phenytoin sodium (USP) <JP/US>
    SCN5A
     D02103  Phenytoin sodium (USP) <JP/US>
    SCN8A
     D02103  Phenytoin sodium (USP) <JP/US>
    SCN9A
     D02103  Phenytoin sodium (USP) <JP/US>
    SCN10A
     D02103  Phenytoin sodium (USP) <JP/US>
    SCN11A
     D02103  Phenytoin sodium (USP) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D02103  Phenytoin sodium for injection
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D02103
 Drug transporters
  D02103
Pharmacogenomic biomarkers [br08341.html]
 Polymorphisms and mutations affecting drug response
  D02103
Drug groups [BR:br08330]
 Neuropsychiatric agent
  DG03199  Antiepileptic agent
   DG02031  Hydantoin antiepileptic
    DG00846  Phenytoin
 Metabolizing enzyme substrate
  DG01642  CYP2C9 substrate
   DG00846  Phenytoin
  DG01639  CYP2C19 substrate
   DG00846  Phenytoin
 Metabolizing enzyme inducer
  DG02891  CYP2B6 inducer
   DG00846  Phenytoin
  DG02853  CYP3A/CYP3A4 inducer
   DG00846  Phenytoin
 Transporter inducer
  DG01893  ABCB1 inducer
   DG00846  Phenytoin
Other DBs
CAS: 630-93-3
PubChem: 7849164
LigandBox: D02103
NIKKAJI: J394.728I
KCF data

ATOM        20
            1   Z   Na   16.6434  -17.9173 #+
            2   C1z C    14.9800  -21.4200
            3   N1x N    15.4700  -20.1600
            4   C2y C    14.3500  -19.3900
            5   N2x N    13.1600  -20.1600
            6   C5x C    13.6500  -21.4200
            7   O1a O    14.3500  -17.9200 #-
            8   O5x O    12.8100  -22.6100
            9   C8y C    16.3800  -21.4200
            10  C8x C    17.0800  -22.6800
            11  C8x C    18.5500  -22.6800
            12  C8x C    19.2500  -21.4900
            13  C8x C    18.4800  -20.2300
            14  C8x C    17.0800  -20.2300
            15  C8y C    14.9800  -22.8900
            16  C8x C    13.7900  -23.5200
            17  C8x C    13.7900  -24.9200
            18  C8x C    15.0500  -25.6900
            19  C8x C    16.2400  -24.9900
            20  C8x C    16.2400  -23.5900
BOND        21
            1     2   3 1
            2     3   4 1
            3     4   5 2
            4     5   6 1
            5     2   6 1
            6     4   7 1
            7     6   8 2
            8     2   9 1
            9     9  10 2
            10   10  11 1
            11   11  12 2
            12   12  13 1
            13   13  14 2
            14    9  14 1
            15    2  15 1
            16   15  16 2
            17   16  17 1
            18   17  18 2
            19   18  19 1
            20   19  20 2
            21   15  20 1

» Japanese version   » Back

  All links  
Ontology (9)   
   KEGG BRITE (9)   
Pathway (2)   
   KEGG PATHWAY (2)   
Drug (3)   
   KEGG DGROUP (1)   
   LigandBox (1)   
   SIDER (1)   
Chemical substance (2)   
   PubChem (1)   
   NIKKAJI (1)   
Gene (18)   
   KEGG ORTHOLOGY (9)   
   KEGG GENES (9)   
All databases (34)   

Download RDF
DBGET integrated database retrieval system